Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited life-threatening arrhythmia leading to syncope and sudden cardiac death at a young age. This disease cell model belongs to CPVT1, an autosomal dominant mutations (p.F2483I, also called c.7447T>A) occur in the RYR2 gene. Generating pluripotent stem cells from dermal fibroblasts, then differentiate into cardiac myocytes. This disease cell model provides a platform to explore disease mechanisms in human genetic cardiac disorders.
Specifications | |
---|---|
Organ System | Cardiovascular System |
Disease | CPVT1 |
Target Gene | RYR2 |
Gene Function | Ryanodine receptor type 2 gene (RYR2) is a mediator of calcium release in the sarcoplasmic reticulum (SR). |
Mutation | p.F2483I (c.7447T>A) |
Phenotype | Increased diastolic Ca2+, delayed afterdepolarisations (DADs) upon adrenergic stimulation |
Source | Dermal fibroblasts |
Cellular Assays | Whole-cell current and voltage clamp, calcium imaging techniques, immunocytochemical staining |
For Research Use Only. Not For Clinical Use.